We added the following clinical trials to Metastatic Trial Search for October 2024. To see all clinical trials, please visit Metastatic Trial Search.
ER or PR Positive Trials
- Stereotactic Body Radiation Therapy and FES PET/CT Scans for Oligoprogressive Metastatic ER+ Breast Cancer
- Saruparib PARP1 Inhibitor with Camizestrant Hormone Therapy for Advanced HR+, HER2- or HER2 Low Breast Cancer with BRCA1, BRCA2, or PALB2 Mutations
HER2 Negative Trials
Other Stage IV Trials
- QXL138AM Immunotherapy for Advanced Breast Cancer
- CID-078 Targeted Therapy for Advanced Breast Cancer
- MOMA-313 Targeted Therapy Alone or with PARP Inhibitor for Advanced Breast Cancer with HRD Mutations
- Immunotherapy and Radiation for Advanced CEA Positive Breast Cancer
- 177Lu-FAP-2286 Radioactive Drug for Advanced Breast Cancer
- Magnetic Resonance Fingerprinting to Distinguish Between Radiation Damage and Brain Tumor Progression
Last Modified on October 1, 2024